Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.30
-0.015-1.14%
Last update: Dec 16, 11:03 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AIM ImmunoTech (AIM) stock?
You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.
Who are AIM ImmunoTech (AIM) competitors?
Other companies in AIM ImmunoTech’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Can Fite Biofarma Ltd (AMEX:CANF), AquaBounty Technologies Inc (NASDAQ:AQB), Indaptus Therapeutics Inc (NASDAQ:INDP) and Protagenic Therapeutics Inc (NASDAQ:PTIX).
What is the forecast, or price target, for AIM ImmunoTech (AIM) stock?
AIM ImmunoTech has a consensus price target of $11.50.
What is the current price for AIM ImmunoTech (AIM)?
The stock price for AIM ImmunoTech (AMEX: AIM) is $1.305 last updated December 16, 2025 at 11:03 AM EST.
Does AIM ImmunoTech (AIM) pay a dividend?
There are no upcoming dividends for AIM ImmunoTech.
When is AIM ImmunoTech (AMEX:AIM) reporting earnings?
AIM ImmunoTech does not have any upcoming earnings scheduled.
Is AIM ImmunoTech (AIM) going to split?
There is no upcoming split for AIM ImmunoTech.
What sector and industry does AIM ImmunoTech (AIM) operate in?
AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
